» Articles » PMID: 27615403

Behavioral Risk Assessment for Infectious Diseases (BRAID): Self-report Instrument to Assess Injection and Noninjection Risk Behaviors in Substance Users

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2016 Sep 13
PMID 27615403
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Infectious diseases such as Human Immunodeficiency Virus and Hepatitis C are a significant problem among substance abusers. Current risk behavior measures [e.g., HIV Risk Taking Behaviour Scale (HRBS) and Risk Assessment Battery (RAB)] were developed for injection drug users and do not include newly identified risks or noninjection drug use behaviors. This study developed and provided initial, internal validation of the Behavioral Risk Assessment for Infectious Diseases (BRAID) to assess infectious disease risk behaviors among alcohol and other drug users.

Methods: A self-report measure was developed from literature regarding risk behaviors. Participants (total N=998) with alcohol/substance use disorder completed the measure in 2 phases to establish initial psychometric validity.

Results: Phase 1 (N=270) completed 65 self-report questions; factor analysis revealed a 12-item solution with 5 factors (Unprotected Sex with Risky Partners, Injection Use, Sex on Cocaine/Crack, Condom Availability, and Intranasal Drug Use). Infectious disease history was positively associated with Injection Use (Sample 1) and Unprotected Sex with Risky Partners (Sample 2) and negatively associated with Intranasal Drug Use (Samples 1 and 2). Phase 2 (N=728) added additional injection-related items and confirmed the factor structure of the existing BRAID.

Conclusions: The BRAID is a 5-factor, 14-item self-report measure of past 6 month risk behaviors that is composed of noninjection and injection risk behaviors and was psychometrically confirmed. Though additional external (convergent/divergent) validation is needed, this report provides preliminary support for the use of the BRAID to assess infectious disease risk in substance users.

Citing Articles

Within-subject evaluation of interim buprenorphine treatment during waitlist delays.

Oleskowicz T, Ochalek T, Peck K, Badger G, Sigmon S Drug Alcohol Depend. 2021; 220:108532.

PMID: 33508690 PMC: 8148627. DOI: 10.1016/j.drugalcdep.2021.108532.


Leveraging crowdsourcing methods to collect qualitative data in addiction science: Narratives of non-medical prescription opioid, heroin, and fentanyl use.

Strickland J, Victor G Int J Drug Policy. 2019; 75:102587.

PMID: 31751813 PMC: 6957729. DOI: 10.1016/j.drugpo.2019.10.013.


A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study.

Ochalek T, Heil S, Higgins S, Badger G, Sigmon S Drug Alcohol Depend. 2018; 190:224-228.

PMID: 30056321 PMC: 6446902. DOI: 10.1016/j.drugalcdep.2018.05.032.


Sexual HIV risk behavior outcomes of brief interventions for drug use in an inner-city emergency department: Secondary outcomes from a randomized controlled trial.

Bonar E, Walton M, Barry K, Bohnert A, Chermack S, Cunningham R Drug Alcohol Depend. 2018; 183:217-224.

PMID: 29291549 PMC: 5803438. DOI: 10.1016/j.drugalcdep.2017.10.036.


Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV.

Johnson M, Herrmann E, Sweeney M, LeComte R, Johnson P Psychopharmacology (Berl). 2016; 234(4):599-612.

PMID: 27921140 PMC: 5343757. DOI: 10.1007/s00213-016-4493-5.

References
1.
Volkow N, Wang G, Fowler J, Telang F, Jayne M, Wong C . Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry. 2007; 164(1):157-60. DOI: 10.1176/ajp.2007.164.1.157. View

2.
El-Bassel N, Gilbert L, Rajah V . The relationship between drug abuse and sexual performance among women on methadone. Heightening the risk of sexual intimate violence and HIV. Addict Behav. 2003; 28(8):1385-403. DOI: 10.1016/s0306-4603(02)00266-6. View

3.
Hagan H, Thiede H, Weiss N, Hopkins S, Duchin J, ALEXANDER E . Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001; 91(1):42-6. PMC: 1446500. DOI: 10.2105/ajph.91.1.42. View

4.
Conrad C, Bradley H, Broz D, Buddha S, Chapman E, Galang R . Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(16):443-4. PMC: 4584812. View

5.
Griffiths P, Gossop M, Powis B, Strang J . Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction. 1994; 89(3):301-9. DOI: 10.1111/j.1360-0443.1994.tb00896.x. View